Medindia
Medindia LOGIN REGISTER
Advertisement

Alliar Announces 3Q17 Results

Thursday, November 9, 2017 General News
Advertisement
BELO HORIZONTE, Brazil, Nov. 8, 2017 /PRNewswire/ -- Centro de Imagem Diagnósticos S.A. ("Alliar" or "Company") (B3: AALR3), announces today its results for the third quarter of 2017 (3Q17).
Advertisement

Highlights:

  • Net revenue1 growth of 14.0% in Q3, with same store sales of 7%. YTD growth of 18.0%, SSS of 11%
  • Acceleration of the 2017-2018 organic expansion plan, with the opening of 1 new mega store (reaching a total of 6 inaugurations LTM); final investments on RBD's 11 hospitals
  • EBITDA growth of 9.1%, reaching R$ 55.6 million in Q3, with adjusted EBITDA totaling R$ 62.4 million (+2.3%). YTD adjusted EBITDA of R$ 171.3 million (+10.3%)
  • Net income (after minority interests) growth of 1811%, reaching R$ 10.2 million in Q3, a R$ 9.7 million expansion YoY
  • Operating cash flow of R$ 45.3 million in Q3 (+85.1%), with 73% cash conversion
  • Issuance of R$ 270.0 million in bonds (concluded in October), with R$ 168.5 million due in 3 years at a cost of 116% of the risk-free rate, and R$ 101.5 million due in 5 years, at a cost of 118% of the risk-free rate
  • Net promoter score (NPS) of 74.0%
For Further Information: ir.alliar.com  
Advertisement

1Excludes "construction revenue", accounting entry referring to the investment made at RBD (PPP Bahia).  

View original content:http://www.prnewswire.com/news-releases/alliar-announces-3q17-results-300552574.html

SOURCE Centro de Imagem Diagnósticos S.A.

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close